Abstract:Background: Dehydroepiandrosterone (DHEA) derived from adrenal cortex has an indirect bioeffect through differentiating into androgen or estrogen in the related peripheral tissues. Objective: To verify the effects and mechanisms of DHEA on promoting osteoblasts (OBs) proliferation. Design, time and setting: The grouping controlled experiment was accomplished in Shanghai Sixth People's Hospital affiliated to Shanghai Jiao Tong University and Institute of Radiation Medicine, Fudan University from January 2006 to February 2007. Materials: Ten SD rats were recruited, 1 day old, regardless of gender. DHEA was the product of American Sigma Company. Methods: Rat OBs were separated and cultured in vitro. First generation of OBs cultured in a varied concentrations of DHEA (1 × 10-5, 1 × 10-7 and 1 × 10-9 mmol/L) for 72 hours were set up as the experiment group, while those exposed to 1 × 10-8 mmol/L of estradiol culture were regarded as positive controls and blank control group was set up as well. Main outcome measures: The OBs were identified by cell morphology and alkaline phosphatase (ALP) dyeing. Light microscope and methyl thiazolyl tetrazolium assay were used to detect the growth and proliferation of OBs. The formation of mineralized nodus was examined by alizarin bordeaux stain. The concentrations of osteoprotegerin in DHEA culture solution were also measured by double antibody sandwich ABC-ELISA simultaneously. Results: 1 Identification of primarily cultured OBs showed ALP dyeing was positive. 2 Proliferation rate of OBs was increased in experiment groups compared with that of the blank control group, and the most significant increase occurred in the concentration of 1 × 10-7 mmol/ L DHEA culture (P < 0.01). However, there was no significant difference in proliferation rate between estradiol culture and DHEA group (P > 0.05). 3 ALP activity in experiment groups was higher, especially in the group with the concentration of 1 × 10-7 nmol/L DHEA (P < 0.01). No significant differences were seen in the ALP activity between estradiol culture and DHEA groups with concentration of 1 × 10-7 and 1 × 10-9 mmol/L (P > 0.05). 4 ALP activity of unitary cell population was higher in 1 × 10-9 mmol/L DHEA culture group than that in blank control group (P < 0.05). 5 Both the area and area ratio of mineralized nodules were significantly increased in various concentrations of DHEA groups (P < 0.01), which was similar to that of estradiol culture. 6 Responds of osteoprotegerin to DHEA were the most active in 1 × 10-9 mmol/L DHEA group after 72 hours of the culture (P < 0.01), and had a positive correlation with OBs proliferation. Conclusion: DHEA may promote growth and proliferation of rat OBs, its effect at the optimal concentration of 1 × (10-7 - 10-9) mmol/L is identical with estradiol, and might be related to stimulating osteoprotegerin pathway DHEA at the concentration exceeding 1 × 10-5 mmol/L has no effect on OBs proliferation.

Dehydroepiandrosterone Indirectly Inhibits Human Osteoclastic Resorption Via Activating Osteoblastic Viability by the MAPK Pathway.

Dehydroepiandrosterone Inhibited the Bone Resorption Through the Upregulation of OPG/RANKL.

Inhibition Mechanism of Bone Resorption by Dehydroepiandrosterone

Dehydroepiandrosterone Improves Murine Osteoblast Growth and Bone Tissue Morphometry Via Mitogen-Activated Protein Kinase Signaling Pathway Independent of Either Androgen Receptor or Estrogen Receptor.

Up-regulation of ERβ in Murine Osteoblasts with the Action of Dehydroepiandrosterone

Effects of dehydroepiandrosterone on in vitro cultured osteoblasts and osteoprotegerin in rats

DHEA Promotes Osteoblast Differentiation by Regulating the Expression of Osteoblast-Related Genes and Foxp3(+) Regulatory T Cells.

Dehydroepiandrosterone and Experimental Osteoarthritis.

Dehydroepiandrosterone: Molecular mechanisms and therapeutic implications in osteoarthritis

DHEA Prevents Bone Loss by Suppressing the Expansion of CD4(+) T Cells and TNFa Production in the OVX-mouse Model for Postmenopausal Osteoporosis.

12-Deoxyphorbol 13-Acetate Inhibits RANKL-induced Osteoclastogenesis Via the Attenuation of MAPK Signaling and NFATc1 Activation

Dehydroepiandrosterone(DHEA) increases Th1 bias and stimulates the proliferative ability of osteoblasts in ovariectomized mice

Effects of Dehydroepiandrosterone on Metabolism of Rat Osteoblasts and IL-1β in Vitro

The Effects of Dehydroepiandrosterone on Metabofism of Rat Osteoblasts and Cytokine in Vitro

Suppression of aggrecanase: a novel protective mechanism of dehydroepiandrosterone in osteoarthritis?

The Chondroprotective Effects of Dehydroepiandrosterone Probably Exerted by Its Conversion to Estradiol

[Selective ERβ Action of Dehydroepiandrosterone for Osteoblast Cell Line].

DHEA suppresses longitudinal bone growth by acting directly at growth plate through estrogen receptors.

The Disease-Modifying Effect of Dehydroepiandrosterone in Different Stages of Experimentally Induced Osteoarthritis: a Histomorphometric Study

Dehydrocostus lactone attenuates osteoclastogenesis and osteoclast-induced bone loss by modulating NF-κB signalling pathway.

A Possible Mechanism in DHEA-mediated Protection Against Osteoarthritis